Collectively, these findings support a diagnostic and prognostic role for SYNGR3 in HNSC, and potentially other HPV(+) cancers, and indicate that detection of SYNGR3 can be accomplished by pathologic analysis of the tumor stroma, making it distinct yet complementary to currently available HPV detection assays. Here, SYNGR3 is linked to neoplasm.